Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,217,192 papers from all fields of science
Search
Sign In
Create Free Account
infliximab Injection [Remicade]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Injection
Remicade
Narrower (1)
infliximab 100 MG Injection [Remicade]
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Five-year Safety Data From OPUS, A European Observational Safety Registry For Adults With Ulcerative Colitis Treated With Originator Infliximab [Remicade®] Or Conventional Therapy.
J. Panés
,
J. Lindsay
,
+9 authors
W. Reinisch
Journal of Crohn's & Colitis
2019
Corpus ID: 73506089
BACKGROUND AND AIMS The Observational Postmarketing Ulcerative colitis Study (OPUS) was conducted to obtain the first long-term…
Expand
Review
2018
Review
2018
Structural Biology of the TNFα Antagonists Used in the Treatment of Rheumatoid Arthritis
Heejin Lim
,
Sang Hyung Lee
,
+4 authors
Y. Heo
International Journal of Molecular Sciences
2018
Corpus ID: 3798251
The binding of the tumor necrosis factor α (TNFα) to its cognate receptor initiates many immune and inflammatory processes. The…
Expand
2018
2018
Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: results of a multicenter study after 12 months.
M. G. Guerra Veloz
,
J. M. Vázquez Morón
,
+9 authors
F. Argüelles Arias
Revista Espanola de Enfermedades Digestivas
2018
Corpus ID: 48363209
BACKGROUND AND AIMS infliximab has changed the natural history of inflammatory bowel disease (IBD). The advent of biosimilar…
Expand
2015
2015
Dextrose-mediated aggregation of therapeutic monoclonal antibodies in human plasma: Implication of isoelectric precipitation of complement proteins
Shen Luo
,
Baolin Zhang
mAbs
2015
Corpus ID: 18144180
Many therapeutic monoclonal antibodies (mAbs) are clinically administered through intravenous infusion after mixing with a…
Expand
2014
2014
Interference of therapeutic monoclonal immunoglobulins in the investigation of M-proteins
J. Ruinemans-Koerts
,
C. Verkroost
,
+4 authors
M. van Luin
Clinical Chemistry and Laboratory Medicine
2014
Corpus ID: 21614820
2013
2013
Intravitreal bevacizumab combined with infliximab in the treatment of choroidal neovascularization secondary to age-related macular degeneration: case report series.
L. Freitas
,
D. Isaac
,
+5 authors
M. Ávila
Arquivos Brasileiros de Oftalmologia
2013
Corpus ID: 27548147
PURPOSE To evaluate the feasibility of the combined use of bevacizumab (Avastin®) and combined with infliximab (Remicade®) in the…
Expand
2012
2012
A case report: ulcerative colitis, treatment with an antibody against tumor necrosis factor (infliximab), and subsequent liver necrosis.
U. Kinnunen
,
M. Färkkilä
,
H. Mäkisalo
Journal of Crohn's & Colitis
2012
Corpus ID: 12705209
2012
2012
Analytical and clinical evaluation of a new immunoassay for therapeutic drug monitoring of infliximab and adalimumab
F. Llinares-Tello
,
J. Rosas-Gómez de Salazar
,
+4 authors
J. Molina-García
Clinical Chemistry and Laboratory Medicine
2012
Corpus ID: 42965649
In the last decade, biological agents have revolutionised rheumatology. Tumour necrosis factorα (TNF α ) neutralising antibody…
Expand
2011
2011
Infliximab in Drug-Naïve Patients with Failed Ileorectal Anastomosis for Crohn’s Disease: A New Chance for Sparing the Rectum?
G. Sciaudone
,
Gianluca Pellino
,
Gabriele Riegler
,
F. Selvaggi
European Surgical Research
2011
Corpus ID: 37753542
The aim of this intervention study is to determine whether long-term infliximab therapy can decrease the proctectomy rate in…
Expand
2004
2004
Infliximab (Remicade) for acute, severe pustular and erythrodermic psoriasis.
S. Lisby
,
R. Gniadecki
Acta Dermato-Venereologica
2004
Corpus ID: 19101861
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required